Pancreas retransplantation: outcomes of 20 cases.
The objective of this paper was to evaluate our initial experience with pancreas retransplantation. From January 26, 1996 to February 2005, 285 pancreas transplantations were performed, including 20 (7%) retransplants. The causes of primary graft loss were graft thrombosis in 11 (55%, 7 venous and 4 arterial); 4 (20%) chronic rejections; 2 (10%) ischemia/reperfusion injury; 1 severe graft pancreatitis; 1 primary nonfunction; and 1 sepsis. Venous drainage was placed in the iliac vessels in 14 (70%), vena cava in 5 (25%), and portal drainage in 1. The exocrine drainage was vesical in 16 (80%) and enteric in 4 (20%). In 14 cases (70%), the primary graft was removed before and in 6 (30%) at the time of retransplantation. Immunosuppression was based on antilymphocyte induction, tacrolimus, mycophenolate mofetil, and steroids in all patients. One-year patient and graft survivals were 95% and 85%. In conclusion, pancreas retransplants were feasible with results comparable to a primary pancreas transplantation.
Genzini
T
T
HEPATO, Hepatology and Organ Transplantation Department, Albert Einstein Hospital, São Paulo, Brazil.
Crescentini
F
F
Torricelli
F C M
FC
Antunes
I
I
Hayashi
A
A
Kim
N J
NJ
Rangel
E B
EB
Belieacqua
E R
ER
Noujaim
H
H
de Sa
J R
JR
Perosa
M
M
D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D006801:Humans; D016030:Kidney Transplantation / Q000706:statistics & numerical data; D016035:Pancreas Transplantation / Q000706:statistics & numerical data*; D012086:Reoperation / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D016896:Treatment Outcome